Amy L. Billett

Amy L. Billett

Auto-generated profile, based on publicly available information

Amy L. Billett

Quality and Safety Program Nemours Children's Health, Delaware Valley Wilmington Delaware USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2019 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
CDChristopher E Dandoy
Christopher E Dandoy
TKTammy Kelley
Tammy Kelley
AGAditya H. Gaur
Aditya H. Gaur
RNRajaram Nagarajan
Rajaram Nagarajan
KDKathy Demmel
Kathy Demmel
ABAmy L. Billett
Amy L. Billett

9 May 2020 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
HHHana Hakim
Hana Hakim
ABAmy L. Billett
Amy L. Billett
JXJiahui Xu
Jiahui Xu
LTLi Tang
Li Tang
TRTroy Richardson
Troy Richardson
CNChildren's Hospital Association Childhood Cancer and Blood Disorders Network
Children's Hospital Association Childhood Cancer and Blood Disorders Network

27 January 2023 in Cancer
Verified
Journal Article
Closed access
CWChris I. Wong
Chris I. Wong
KVKathryn Vannatta
Kathryn Vannatta
JMJordan Gilleland Marchak
Jordan Gilleland Marchak
EQEmeric V. Quade
Emeric V. Quade
IRIsabelle M. Rodgers
Isabelle M. Rodgers
KWKathleen E. Walsh
Kathleen E. Walsh

11 July 2017 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
PDF file
NONmazuo W. Ozuah
Nmazuo W. Ozuah
HDHisham M. Dahmoush
Hisham M. Dahmoush
FGFrederick D. Grant
Frederick D. Grant
LLLeslie E. Lehmann
Leslie E. Lehmann
ALAnn S. LaCasce
Ann S. LaCasce
SMSteven P. Margossian
Steven P. Margossian

16 April 2015
Verified
Book Chapter
Closed access
PDF file
NTNancy J. Tarbell
Nancy J. Tarbell
RSR. Michael Scott
R. Michael Scott
LGLiliana C. Goumnerova
Liliana C. Goumnerova
SPScott L. Pomeroy
Scott L. Pomeroy
PBPeter McL. Black
Peter McL. Black
JLJay S. Loeffler
Jay S. Loeffler

20 October 2014 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
PAPrasanna Ananth
Prasanna Ananth
NANatasha M. Archer
Natasha M. Archer
NCNatalie Bucheimer Collins
Natalie Bucheimer Collins
SCStacy Croteau
Stacy Croteau
AHAndrew Hong
Andrew Hong
ABAmy Billett
Amy Billett
222 Background: Given the risk of serious bacterial infection in immunocompromised cancer patients, fever should be promptly treated with empiric antibiotics. Our institutional standard is to administer antibiotics in ≤ 60 minutes from on-site fever or from arrival time with known fever. Review of our febrile outpatient pediatric oncology clinic patients from October-December 2013 revealed that 53% met this metric. Our aim: To achieve a sustained rate of 80% of febrile patients receiving antibiotics in ≤ 60 minutes within 8 weeks. Methods: We developed and implemented a fever fast track tool in our pediatric oncology clinic. Providers time stamped each step in the process from fever to antibiotic administration; additional time points were collected from the medical record. Interviews with staff were conducted to identify barriers. Five revisions of the fever fast track tool were made. We also streamlined same-day encounters for febrile patients in order to flag their acute visits and facilitate pre-arrival order entry. Results: 21 patients were treated for fever between 2/26/14 and 4/17/14. 4 fevers were documented in clinic. Time to antibiotics ranged from 23 minutes to 165 minutes. The median time to antibiotic administration was reduced from 58 minutes during the first four weeks to 40 minutes after the second 4-week block. Over the same period, patients receiving antibiotics in ≤ 60 minutes increased from 62% to 88%. Conclusions: Use of a fever fast track tool improved the proportion of febrile patients receiving antibiotics in ≤ 60 minutes. Modifications facilitating antibiotic order entry and pre-arrival awareness of febrile patients should prove helpful in sustaining this success.